Training program for developing new brain therapies
Training in Neurotherapeutics for Academic Scientists
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA AT DAVIS · NIH-10912751
This study is all about helping scientists and advanced researchers learn how to create new treatments for brain diseases through a friendly 4-day training course that covers everything from finding drug targets to working with the FDA.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA AT DAVIS (nih funded) |
| Locations | 1 site (DAVIS, UNITED STATES) |
| Trial ID | NIH-10912751 on ClinicalTrials.gov |
What this research studies
This project focuses on creating a training program for academic scientists and advanced postdoctoral fellows in the field of neurotherapeutics. The program includes a 4-day course that covers essential knowledge for discovering and developing new treatments for brain diseases. Participants will learn about drug discovery targets, assay construction, medicinal chemistry, animal testing, and regulatory processes, including how to interact with the FDA. The training aims to equip participants with the skills necessary to advance neurotherapeutic agents from concept to clinical application.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research are academic scientists and advanced postdoctoral fellows interested in neurotherapeutics.
Not a fit: Patients who are not involved in academic research or do not have a background in neuroscience may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for various brain disorders.
How similar studies have performed: Other training programs in drug discovery have shown success in enhancing the capabilities of researchers, indicating that this approach is promising.
Where this research is happening
DAVIS, UNITED STATES
- UNIVERSITY OF CALIFORNIA AT DAVIS — DAVIS, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: ROGAWSKI, MICHAEL A. — UNIVERSITY OF CALIFORNIA AT DAVIS
- Study coordinator: ROGAWSKI, MICHAEL A.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.